Announcement on Subsidiary Passing the US FDA's Routine On-Site CGMP Inspection
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Subsidiary Passing the US FDA's Routine On-Site CGMP Inspection
Filed with SSE · · 2 pages · Chinese
Release
Tianjin Tianyao Pharmaceuticals Co., Ltd. on 6ix
Later from Tianjin Tianyao Pharmaceuticals
- Announcement on Renewing Engagement of Accounting Firm
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Provision for Impairment
- Announcement on Receiving Decision for Administrative Penalty
- Announcement on Convening the 2024 Annual Performance Briefing
Follow Tianjin Tianyao Pharmaceuticals into a list and get an email when it puts out news.
Follow Tianjin Tianyao Pharmaceuticals